HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer.

Abstract
Overexpression of cyclin-dependent kinase 1 (CDK1) has been noted to correlation with several human cancers. However, the effects of CDK1 on ovarian cancer development remain unclear. The aim of this study was to examine the effect of CDK1 and related mechanism in the proliferation and resistance to chemotherapeutic drugs of epithelial ovarian cancer (EOC). Immunohistochemical analysis was performed in 119 human ovarian cancer samples, and the data were correlated with clinicopathologic features. Furthermore, Western blot analysis was performed for CDK1 in EOC samples and cell lines to evaluate their protein levels and molecular interaction. Kaplan-Meier survival analysis showed that strong expression of CDK1 exhibited a significant correlation with poor prognosis in human EOC (P = 0.02). Meanwhile, we found that knockdown CDK1 by shCDK1 promoted the apoptosis rate and increased the sensitivity to chemotherapy drugs. Thus, CDK1 might serve as a prognostic marker, and it might be of great value for experimental therapies in EOC.
AuthorsQinghua Xi, Menghui Huang, Yingying Wang, Jianxin Zhong, Rong Liu, Guiqin Xu, Lifei Jiang, Juan Wang, Zheng Fang, Shuyun Yang
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 36 Issue 7 Pg. 4939-48 (Jul 2015) ISSN: 1423-0380 [Electronic] Netherlands
PMID25910705 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDC2 Protein Kinase
  • CDK1 protein, human
  • Cyclin-Dependent Kinases
  • Cisplatin
Topics
  • Adult
  • Aged
  • CDC2 Protein Kinase
  • Carcinoma, Ovarian Epithelial
  • Cell Proliferation (drug effects)
  • Cell Survival
  • Cisplatin (administration & dosage)
  • Cyclin-Dependent Kinases (biosynthesis, genetics)
  • Drug Resistance, Neoplasm (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kaplan-Meier Estimate
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Glandular and Epithelial (epidemiology, genetics, pathology)
  • Ovarian Neoplasms (epidemiology, genetics, pathology)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: